Ingredient
Diaminopyrimidine Oxide
Diaminopyrimidine Oxide is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is absorbed into the body and fetal development.
- Minoxidil
- Kopexil
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Diaminopyrimidine Oxide and pregnancy
Caution Advised
- Absorbed into the body
- Fetal development
Diaminopyrimidine Oxide is a synthetic compound used in hair care products to stimulate hair growth and improve scalp health. It works by prolonging the anagen (growth) phase of hair follicles and increasing blood circulation to the scalp. While specific studies on topical diaminopyrimidine oxide during pregnancy are limited, it's chemically related to minoxidil, which the FDA classifies as pregnancy category C. Pharmaceutical minoxidil has shown adverse effects in animal studies, and some systemic absorption can occur with topical application. The concern is that absorbed compounds could potentially affect fetal development, particularly cardiovascular development, though cosmetic concentrations are lower than pharmaceutical doses. Most dermatologists recommend avoiding hair growth stimulants during pregnancy due to theoretical risks and lack of comprehensive safety data. While the risk with cosmetic concentrations is likely lower than pharmaceutical minoxidil, many practitioners advise waiting until after pregnancy to use products containing this ingredient as a precautionary measure.
Diaminopyrimidine Oxide and breastfeeding
Caution Advised
- Passes into breast milk
- Infant exposure
Diaminopyrimidine Oxide is a hair growth stimulant that can be absorbed through the scalp into the bloodstream, though absorption rates with cosmetic concentrations are generally lower than pharmaceutical formulations. The primary concern during breastfeeding is whether absorbed compound could transfer into breast milk. Similar to its pharmaceutical relative minoxidil, there's theoretical concern about systemic absorption and potential transfer to breast milk. The American Academy of Pediatrics and lactation consultants generally recommend avoiding topical medications and hair growth stimulants during breastfeeding due to unknown effects on breastfed infants. While cosmetic concentrations are lower, the lack of specific safety data for breastfeeding women makes it difficult to definitively assess risk. Most healthcare providers suggest postponing use of hair growth stimulants until after weaning. If hair loss is a concern during the postpartum period, dermatologists may recommend gentler alternatives like biotin supplements, scalp massage, or peptide-based hair serums that have better-established safety profiles for breastfeeding mothers.
Diaminopyrimidine Oxide and postpartum
Safe to Use
Diaminopyrimidine Oxide can be particularly beneficial for postpartum women experiencing hair loss, as it helps stimulate follicle activity and promote hair regrowth. Postpartum hair loss (telogen effluvium) typically peaks 3-6 months after delivery, and this ingredient may help accelerate the recovery process. For women who are not breastfeeding, there are no specific contraindications to using this hair growth stimulant. It can be safely incorporated into a hair care routine to address postpartum shedding, though it may take 2-3 months of consistent use to see visible improvements. Mild scalp irritation is the main potential side effect.
Diaminopyrimidine Oxide and trying to conceive
Caution Advised
- Absorbed into the body
Diaminopyrimidine Oxide's relationship to minoxidil raises similar concerns for women trying to conceive. While there's no direct evidence that it affects fertility, the theoretical risk of systemic absorption and potential early pregnancy exposure leads many doctors to recommend caution. Most fertility specialists and dermatologists suggest discontinuing hair growth stimulants once actively trying to conceive, as you may become pregnant before realizing it. The first trimester is the most critical period for fetal development, and avoiding unnecessary exposures during this time is prudent. If hair loss treatment is important, discuss alternative options with your healthcare provider.
Diaminopyrimidine Oxide and PCOS
Safe to Use
Diaminopyrimidine Oxide can be beneficial for women with PCOS who experience androgenic alopecia (male-pattern hair loss) or diffuse hair thinning related to hormonal imbalances. It works by stimulating hair follicles directly without interfering with hormonal pathways. This ingredient does not affect androgen levels or insulin sensitivity, making it safe for PCOS management alongside other treatments. Many dermatologists recommend it as part of a comprehensive approach to managing PCOS-related hair loss, often combined with anti-androgen treatments or supplements like spironolactone or inositol. The non-hormonal mechanism makes it a versatile option that can be used long-term without concerns about hormone disruption. Women with PCOS should maintain realistic expectations, as results typically appear gradually over 3-6 months of consistent use.
Diaminopyrimidine Oxide and general use
Safe to Use
- Irritant
Diaminopyrimidine Oxide is a well-tolerated hair growth ingredient for the general population. It's designed to stimulate hair follicles, extend the growth phase of hair, and improve overall hair density and thickness. Commonly found in hair serums, shampoos, and scalp treatments. The main side effect is mild scalp irritation, which occurs in a small percentage of users. This typically manifests as redness, itching, or dryness at the application site. These effects are usually temporary and resolve with continued use or can be managed by reducing application frequency. For optimal results, consistent use over several months is required. It's generally considered safe for long-term use in the general population, with a lower side effect profile than pharmaceutical minoxidil due to lower concentrations in cosmetic products.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Diaminopyrimidine Oxide, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store